Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody
2001; Springer Science+Business Media; Volume: 74; Issue: 1 Linguagem: Inglês
10.1007/bf02982552
ISSN1865-3774
AutoresTakahiro Maeda, Yasuaki Yamada, Masayuki Tawara, Reishi Yamasaki, Yuichi Yakata, Chizuko Tsutsumi, Yasuyuki Onimaru, Simeru Kamihira, Masao Tomonaga,
Tópico(s)Vascular Tumors and Angiosarcomas
Referência(s)